Sébastien Mas – CEO, Skyepharma
Skyepharma stands at a defining moment. With new shareholders, expanding high-potency and bioproduction capabilities and a sharpened focus on complex oral forms, the French CDMO is positioning itself for a…
Business Solutions is the team of experts at Disneyland Paris, dedicated to organizing large venue events for companies, conferences, and congresses. Disneyland Paris is a unique venue and now the largest all-in-one destination for business tourism in Europe. With its own rail terminal, state-of-the-art congress centers, hotels, restaurants and a huge range of activities on offer, Disneyland Paris offers everything a company may need to make an event an outstanding success! With a staff of 150, Disney Business Solutions has a team of specialists ready to customize any type of event in the various Disneyland Paris venues available for events, including plenary rooms or exhibition areas. With a series of hotels and restaurants nearby, all event attendees are in a close, easily navigable site, also in proximity to the amenities of Disneyland Paris’ two theme parks. The venue is conveniently reached by all modes of transportation including local and regional trains (RER and Eurostar), shuttles from both Charles de Gaulle airport and Orly Airport, as well as a mere 35 minutes drive from Paris.
Contact
+33 160 457 500
Euro Disney Associes S.C.A.
Business Solutions
Boite Postale 112
F-77777 Marne-la-Vallee Cedex 4
Skyepharma stands at a defining moment. With new shareholders, expanding high-potency and bioproduction capabilities and a sharpened focus on complex oral forms, the French CDMO is positioning itself for a…
ANSM’s Director General Catherine Paugam-Burtz offers a clear view of how France’s medicines agency is adapting to a fast-shifting landscape. She discusses ANSM’s role within the European regulatory system, the…
Pascaline Gervoson, CEO of PiLeJe, a family-owned French nutraceutical company, represents the second generation of leadership following her father’s founding vision in 1992. With 27 years within the organisation and…
ISISPHARMA’s story unfolds through the Dewavrin group’s evolution from textile manufacturing into a science driven portfolio spanning dermocosmetics and micronutrition. Grégoire Dewavrin explains how the brand has grown through a…
At a time when France’s healthcare landscape is being reshaped by regulatory change, market pressure, and shifting patient expectations, Fabrice Ruggeri, Country Manager of Organon France, is steering the affiliate…
Under the leadership of Nicolas Bardonnet, Promega France has expanded its role from a broad portfolio provider to a more collaborative partner supporting key human health applications. Bardonnet has integrated…
Benta Lyon is reshaping its industrial footprint with unusual speed, combining a fast-growing CDMO platform, an expanding French made generics portfolio and new sterile capabilities that will anchor its next…
argenx has moved from an antibody engineering start-up to one of Europe’s most closely-watched biotechs, advancing a pipeline that spans multiple autoimmune diseases. In this interview, François Rauch reflects on…
With over 25 years of experience at the crossroads of science and business, Pascal Villemagne, CEO of SEQENS, shares his vision for steering the French CDMO into a new era…
France’s territorial landscape is undergoing a profound shift, and departments are emerging as decisive actors in the response to medical deserts, demographic ageing and the widening gaps in prevention and…
Jerome Estampes, CFO and interim CEO of Guerbet France, discusses his journey from joining the company in 2019 through to his current dual role, navigating the challenges of generic competition,…
Alexion France is entering a pivotal phase as the rare-disease landscape becomes more competitive, more data driven and increasingly shaped by early access and clinical-trial performance. In this interview, Celine…
See our Cookie Privacy Policy Here
